Literature DB >> 142934

Hormonal changes following hypophysectomy in humans.

G C Lachelin, S C Yen, J F Alksne.   

Abstract

Entities:  

Keywords:  Androgens--analysis; Biology; Breast Cancer; Cancer; Clinical Research; Diseases; Endocrine System; Estradiol--analysis; Estrogens; Estrone--analysis; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone--analysis; Neoplasms; Physiology; Pituitary Gland; Pituitary Hormones; Prolactin--analysis; Research Methodology; Testosterone--analysis

Mesh：

Substances：

Year:  1977        PMID： 142934

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  8 in total

1.  Immunohistochemical study of the pars tuberalis of the adenohypophysis in the monkey, Macaca irus.

Authors:  C Girod; M P Dubois; J Trouillas
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

Review 2.  Prolactin as an autocrine/paracrine factor in breast tissue.

Authors:  C V Clevenger; T L Plank
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 3.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

4.  The pars tuberalis of the human pituitary. A histologic, immunohistochemical, ultrastructural and immunoelectron microscopic analysis.

Authors:  S L Asa; K Kovacs; J M Bilbao
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

5.  Bioactive prolactin levels and risk of breast cancer: a nested case-control study.

Authors:  Shelley S Tworoger; Megan S Rice; Bernard A Rosner; Yvonne B Feeney; Charles V Clevenger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-14       Impact factor: 4.254

Review 6.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

7.  A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development.

Authors:  Shelley S Tworoger; A Heather Eliassen; Xuehong Zhang; Jing Qian; Patrick M Sluss; Bernard A Rosner; Susan E Hankinson
Journal:  Cancer Res       Date:  2013-06-19       Impact factor: 12.701

8.  Prolactin acts as a potent survival factor for human breast cancer cell lines.

Authors:  C M Perks; A J Keith; K L Goodhew; P B Savage; Z E Winters; J M P Holly
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.